Authors' Reply
- PMID: 36808851
- PMCID: PMC9983737
- DOI: 10.1097/TP.0000000000004484
Authors' Reply
Conflict of interest statement
A.P.L. has received consulting fees, research support, contracted research, or consulting fees from Amplyx Pharmaceuticals, Novartis, Merck, J&J, NovoNordisc, GSK, NobelPharma, Hologic, and Allovir. H.I. declares no conflicts of interest.
Comment on
-
Changes in Donor and Recipient Demographic Characteristics Over Time Explain the Increasing Prevalence of the High-risk Cytomegalovirus Donor-positive/Recipient-negative Serostatus in Solid Organ Transplant Recipients.Transplantation. 2023 Mar 1;107(3):e82. doi: 10.1097/TP.0000000000004483. Epub 2023 Feb 21. Transplantation. 2023. PMID: 36808850 No abstract available.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
